GB2283021B - A recombinant poxviral vaccine for canine distemper - Google Patents

A recombinant poxviral vaccine for canine distemper

Info

Publication number: GB2283021B
Authority: GB; United Kingdom
Prior art keywords: canine distemper; recombinant poxviral; vaccine; poxviral vaccine; recombinant
Prior art date: 1990-11-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

GB9500214A

Other versions

GB9500214D0 (en

GB2283021A (en

Inventor

Enzo Paoletti

Jill Taylor

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Virogenetics Corp

Original Assignee

Virogenetics Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-11-20

Filing date

1991-11-20

Publication date

1995-07-05

1991-11-20 Application filed by Virogenetics Corp filed Critical Virogenetics Corp

1995-03-01 Publication of GB9500214D0 publication Critical patent/GB9500214D0/en

1995-04-26 Publication of GB2283021A publication Critical patent/GB2283021A/en

1995-07-05 Application granted granted Critical

1995-07-05 Publication of GB2283021B publication Critical patent/GB2283021B/en

2011-11-20 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Wood Science & Technology (AREA)
Communicable Diseases (AREA)
Biomedical Technology (AREA)
Biophysics (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Oncology (AREA)
Zoology (AREA)
Physics & Mathematics (AREA)
Microbiology (AREA)
Plant Pathology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pulmonology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

GB9500214A 1990-11-20 1991-11-20 A recombinant poxviral vaccine for canine distemper Expired - Lifetime GB2283021B (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US62161490A	1990-11-20	1990-11-20
US77686791A	1991-10-22	1991-10-22
GB9309414A GB2264949B (en)	1990-11-20	1991-11-20	Measles virus recombinant poxvirus vaccine

Publications (3)

Publication Number	Publication Date
GB9500214D0 GB9500214D0 (en)	1995-03-01
GB2283021A GB2283021A (en)	1995-04-26
GB2283021B true GB2283021B (en)	1995-07-05

Family

ID=27089007

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
GB9500214A Expired - Lifetime GB2283021B (en)	1990-11-20	1991-11-20	A recombinant poxviral vaccine for canine distemper
GB9309414A Expired - Lifetime GB2264949B (en)	1990-11-20	1991-11-20	Measles virus recombinant poxvirus vaccine

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
GB9309414A Expired - Lifetime GB2264949B (en)	1990-11-20	1991-11-20	Measles virus recombinant poxvirus vaccine

Country Status (12)

Country	Link
JP (2)	JP3617668B2 (en)
AU (1)	AU1253892A (en)
BE (1)	BE1005908A5 (en)
CA (1)	CA2096633A1 (en)
CH (1)	CH683921A5 (en)
DE (2)	DE4192786B4 (en)
FR (1)	FR2669346B1 (en)
GB (2)	GB2283021B (en)
IE (2)	IE71643B1 (en)
IT (1)	IT1252687B (en)
NL (2)	NL195058C (en)
WO (1)	WO1992008789A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5833975A (en) *	1989-03-08	1998-11-10	Virogenetics Corporation	Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
US5505941A (en) *	1981-12-24	1996-04-09	Health Research, Inc.	Recombinant avipox virus and method to induce an immune response
US5338683A (en)	1981-12-24	1994-08-16	Health Research Incorporated	Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins
US7767449B1 (en)	1981-12-24	2010-08-03	Health Research Incorporated	Methods using modified vaccinia virus
US6248333B1 (en)	1990-04-04	2001-06-19	Health Research Inc.	Isolated nucleic acid sequence of equine herpesvirus type 1 glycoprotein D (EHV-1 gD)
US5756102A (en) *	1990-11-20	1998-05-26	Virogenetics Corporation	Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants
JP3602530B2 (en) *	1991-03-07	2004-12-15	ヴァイロジェネティクスコーポレイション	Genetically engineered vaccine strain
US5989561A (en) *	1991-03-07	1999-11-23	Virogenetics Corporation	Recombinant poxvirus-calicivirus rabbit hemorrhagic disease virus (RHDV) compositions and uses
AU672581B2 (en) *	1991-03-07	1996-10-10	Virogenetics Corporation	Immunodeficiency virus recombinant poxvirus vaccine
JPH06505397A (en) *	1991-03-20	1994-06-23	ヴァイロジェネティクス　コーポレイション	malaria recombinant poxvirus
US5643578A (en)	1992-03-23	1997-07-01	University Of Massachusetts Medical Center	Immunization by inoculation of DNA transcription unit
CN1089370C (en) *	1994-12-08	2002-08-21	中国预防医学科学研究院病毒学研究所	Recombination vaccinia virus for expression of measles virus L4 strain hemagglutinin and fusion protein gene
AU2118997A (en) *	1996-02-05	1997-08-22	Johns Hopkins University, The	Measles immunization by dna transcription unit inoculation
US6211165B1 (en)	1997-05-09	2001-04-03	The Trustees Of The University Of Pennsylvania	Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists
EP1095948A1 (en) *	1999-10-28	2001-05-02	Universitätsklinikum Freiburg	Idiotype vaccines
CA2454959C (en)	2001-03-08	2018-07-10	Bernard Moss	Mva expressing modified hiv envelope, gag, and pol genes
AR052743A1 (en) *	2006-04-11	2007-03-28	Inst Nac De Tecnologia Agropec	PLASMIDIC TRANSFER VECTOR AND RECOMBINANT CANARYPOX VIRUS

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1989003429A1 (en) *	1987-08-28	1989-04-20	Health Research Inc.	Recombinant avipox virus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2617715B1 (en) *	1987-07-07	1990-08-31	Transgene Sa	VIRAL VECTOR AND RECOMBINANT DNA ENCODING FOR ONE OR MORE SURFACE PROTEINS (HA AND / OR F) OF A MORBILLIVIRUS, INFECTED CELL CULTURE, PROTEINS OBTAINED, VACCINE AND ANTIBODIES OBTAINED
FR2632863B2 (en) *	1987-10-29	1990-08-31	Transgene Sa	RECOMBINANT FOWLPOX VIRUS AND VACCINES DERIVED FROM SUCH VIRUSES
JPH01218590A (en) *	1988-02-29	1989-08-31	Toa Nenryo Kogyo Kk	Rinderpest virus vaccine using recombinant vaccinia virus

1991
- 1991-11-13 IE IE960091A patent/IE71643B1/en not_active IP Right Cessation
- 1991-11-13 IE IE396091A patent/IE68404B1/en not_active IP Right Cessation
- 1991-11-19 FR FR9114256A patent/FR2669346B1/en not_active Expired - Lifetime
- 1991-11-19 BE BE9101066A patent/BE1005908A5/en not_active IP Right Cessation
- 1991-11-20 IT ITMI913092A patent/IT1252687B/en active IP Right Grant
- 1991-11-20 JP JP50520492A patent/JP3617668B2/en not_active Expired - Fee Related
- 1991-11-20 GB GB9500214A patent/GB2283021B/en not_active Expired - Lifetime
- 1991-11-20 NL NL9120026A patent/NL195058C/en not_active IP Right Cessation
- 1991-11-20 GB GB9309414A patent/GB2264949B/en not_active Expired - Lifetime
- 1991-11-20 WO PCT/US1991/008703 patent/WO1992008789A1/en active Application Filing
- 1991-11-20 DE DE4192786A patent/DE4192786B4/en not_active Expired - Lifetime
- 1991-11-20 DE DE4192786T patent/DE4192786T1/en active Pending
- 1991-11-20 CH CH2364/92A patent/CH683921A5/en not_active IP Right Cessation
- 1991-11-20 AU AU12538/92A patent/AU1253892A/en not_active Abandoned
- 1991-11-20 CA CA002096633A patent/CA2096633A1/en not_active Abandoned
2003
- 2003-07-15 NL NL9900036A patent/NL195095C/en not_active IP Right Cessation
2004
- 2004-06-09 JP JP2004170929A patent/JP3824619B2/en not_active Expired - Fee Related

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1989003429A1 (en) *	1987-08-28	1989-04-20	Health Research Inc.	Recombinant avipox virus

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Proc.Natl.Acad.Sci. USA, Vol 85, 1988, pages 1252-1256 *

Also Published As

Publication number	Publication date
GB2264949A (en)	1993-09-15
IE68404B1 (en)	1996-06-12
AU1253892A (en)	1992-06-11
IE913960A1 (en)	1992-05-20
JPH06502996A (en)	1994-04-07
DE4192786T1 (en)	1994-01-13
NL9120026A (en)	1993-09-01
GB9309414D0 (en)	1993-07-14
NL9900036A (en)	2003-10-01
CH683921A5 (en)	1994-06-15
ITMI913092A1 (en)	1993-05-20
NL195058C (en)	2003-07-01
FR2669346A1 (en)	1992-05-22
IE71643B1 (en)	1997-02-26
BE1005908A5 (en)	1994-03-08
NL195095C (en)	2004-01-21
GB9500214D0 (en)	1995-03-01
GB2264949B (en)	1995-07-05
DE4192786B4 (en)	2006-08-24
GB2283021A (en)	1995-04-26
FR2669346B1 (en)	1995-07-21
JP2005040129A (en)	2005-02-17
CA2096633A1 (en)	1992-05-21
WO1992008789A1 (en)	1992-05-29
JP3617668B2 (en)	2005-02-09
JP3824619B2 (en)	2006-09-20
ITMI913092A0 (en)	1991-11-20
IT1252687B (en)	1995-06-23

Publication	Publication Date	Title
GB2283021B (en)	1995-07-05	A recombinant poxviral vaccine for canine distemper
AU2371692A (en)	1993-02-11	Recombinant hepatitis a virus vaccine
GB9303023D0 (en)	1993-12-01	Flavivirus recombinant poxvirus vaccine
GB9105992D0 (en)	1991-05-08	Vaccine
EP0717636A4 (en)	1997-05-21	Malaria recombinant poxvirus vaccine
HUP9601466A2 (en)	1997-03-28	Adjuvants for viral vaccines
HUP9601462A2 (en)	1997-03-28	Adjuvants for viral vaccines
HU9500417D0 (en)	1995-04-28	Hepatitis a vaccine
EP0474646A4 (en)	1992-10-21	Bordetella vaccines
HU9300010D0 (en)	1993-04-28	Glycoprotein vaccine named ehv-4
GB9201139D0 (en)	1992-03-11	Synthetic peptides for a rubella vaccine
US5084271B1 (en)	1997-08-05	Vaccine for equine herpesvirus
ZA903142B (en)	1991-02-27	Canine corona virus vaccine
AU4489896A (en)	1996-07-24	Avian recombinant live vaccine
AU110218S (en)	1991-02-07	Over head projector
ZA93919B (en)	1993-11-26	Vaccines
EP0533263A3 (en)	1994-06-08	A multivalent hepatitis b virus vaccine
GB8819836D0 (en)	1988-09-21	Vaccine
EP0912193A4 (en)	2000-11-02	VACCINE FOR PREVENTING STREPTOCOCCAL ENDOCARDITY
ZA924670B (en)	1993-03-31	Ccv vaccine
GB9213882D0 (en)	1992-08-12	Live modified equine herpesvirus-4 vaccine
AU614735C (en)	1994-02-24	Canine distemper virus vaccine
GB9106568D0 (en)	1991-05-15	Recombinant antigen
ZA902894B (en)	1991-01-30	Herpesvirus recombinant poxvirus vaccine
IL95006A0 (en)	1991-06-10	Oral vaccines

Legal Events

Date	Code	Title	Description
2011-12-14	PE20	Patent expired after termination of 20 years	Expiry date: 20111119